Sage Therapeutics: Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025

Sage Therapeutics, Inc. SAGE today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 8:15 a.m. PT in San Francisco, CA. A live webcast of the presentation can be accessed on the Investor page of Sage's website at investor.sagerx.com . A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days. About Sage Therapeutics Sage Therapeutics SAGE is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook , LinkedIn , Instagram , and X . View source version on businesswire.com: https://www.businesswire.com/news/home/20250108981499/en/ Investor Katie Plante Katie.Plante@sagerx.com Media Francesca Dellelci Francesca.Dellelci@sagerx.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.